Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test

Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test

May 17, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Veracyte today said it has launched an early-access program for its Envisia Genomic Classifier test for idiopathic pulmonary fibrosis. The test uses RNA sequencing and machine learning to analyze 190 genes involved in usual interstitial pneumonia, a feature of IPF, with 88 percent specificity and 70 percent sensitivity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Trump Announces Departure From WHO

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

Also, Vacuums Are Just Scary

A study of Great Danes homes in on a genomic region linked to fearfulness.

Limited Early Spread

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

PLOS Papers on Indonesian Archipelago Populations, Hookworm Secretome, Carotid Plaque GWAS

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

  2. Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions

    Premium

  3. Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers

  4. FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

  5. Ginkgo Bioworks Nabs $70M Investment from Illumina, Others to Build Coronavirus NGS Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.